Your browser doesn't support javascript.
loading
TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells.
Wünkhaus, D; Tang, R; Nyame, K; Laqtom, N N; Schweizer, M; Scotto Rosato, A; Krogsæter, E K; Wollnik, C; Abu-Remaileh, M; Grimm, C; Hermey, G; Kuhn, R; Gruber-Schoffnegger, D; Markmann, S.
  • Wünkhaus D; Evotec SE, Hamburg, Germany.
  • Tang R; Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Nyame K; Charles River Laboratory, Chesterford Research Park, Saffron Walden, UK.
  • Laqtom NN; Department of Chemical Engineering and of Genetics and Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
  • Schweizer M; Department of Chemical Engineering and of Genetics and Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
  • Scotto Rosato A; Biological and Environmental Science & Engineering Division, King Abdullah University Of Science And Technology, Thuwal, Saudi Arabia.
  • Krogsæter EK; Core Facility Morphology and Electronmicroscopy, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wollnik C; Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Abu-Remaileh M; Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Grimm C; Gladstone Institutes, San Francisco, CA, USA.
  • Hermey G; Evotec SE, Hamburg, Germany.
  • Kuhn R; Department of Chemical Engineering and of Genetics and Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
  • Gruber-Schoffnegger D; Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Markmann S; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research IIP, Munich/Frankfurt, Germany.
Sci Rep ; 14(1): 17469, 2024 07 29.
Article en En | MEDLINE | ID: mdl-39080379
ABSTRACT
Mutations in the lysosomal membrane protein CLN3 cause Juvenile Neuronal Ceroid Lipofuscinosis (JNCL). Activation of the lysosomal ion channel TRPML1 has previously been shown to be beneficial in several neurodegenerative disease models. Here, we tested whether TRPML1 activation rescues disease-associated phenotypes in CLN3-deficient retinal pigment epithelial (ARPE-19 CLN3-KO) cells. ARPE-19 CLN3-KO cells accumulate LAMP1 positive organelles and show lysosomal storage of mitochondrial ATPase subunit C (SubC), globotriaosylceramide (Gb3), and glycerophosphodiesters (GPDs), whereas lysosomal bis(monoacylglycero)phosphate (BMP/LBPA) lipid levels were significantly decreased. Activation of TRPML1 reduced lysosomal storage of Gb3 and SubC but failed to restore BMP levels in CLN3-KO cells. TRPML1-mediated decrease of storage was TFEB-independent, and we identified TRPML1-mediated enhanced lysosomal exocytosis as a likely mechanism for clearing storage including GPDs. Therefore, ARPE-19 CLN3-KO cells represent a human cell model for CLN3 disease showing many of the described core lysosomal deficits, some of which can be improved using TRPML1 agonists.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteínas de Membrana / Chaperonas Moleculares / Canales de Potencial de Receptor Transitorio / Epitelio Pigmentado de la Retina / Lisosomas / Lipofuscinosis Ceroideas Neuronales Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteínas de Membrana / Chaperonas Moleculares / Canales de Potencial de Receptor Transitorio / Epitelio Pigmentado de la Retina / Lisosomas / Lipofuscinosis Ceroideas Neuronales Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article